BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9305714)

  • 21. Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis.
    Visco C; Nadali G; Vassilakopoulos TP; Bonfante V; Viviani S; Gianni AM; Federico M; Luminari S; Peethambaram P; Witzig TE; Pangalis G; Cabanillas F; Medeiros LJ; Sarris AH; Pizzolo G
    Eur J Haematol; 2006 Nov; 77(5):387-94. PubMed ID: 16879607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.
    Turen S; Ozyar E; Altundag K; Gullu I; Atahan IL
    Cancer Invest; 2007 Aug; 25(5):315-21. PubMed ID: 17661206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors.
    Caballero MD; Rubio V; Rifon J; Heras I; García-Sanz R; Vázquez L; Vidriales B; del Cañizo MC; Corral M; Gonzalez M; León A; Jean-Paul E; Rocha E; Moraleda JM; San Miguel JF
    Bone Marrow Transplant; 1997 Sep; 20(6):451-8. PubMed ID: 9313877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin lymphoma.
    Rossi G; Donisi A; Casari S; Re A; Cadeo G; Carosi G
    Cancer; 1999 Dec; 86(11):2391-7. PubMed ID: 10590382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
    Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors in Hodgkin's disease: multivariate analysis of 327 patients from a single institution.
    Smolewski P; Robak T; Krykowski E; Blasiñska-Morawiec M; Niewiadomska H; Pluzanska A; Chmielowska E; Zambrano O
    Clin Cancer Res; 2000 Mar; 6(3):1150-60. PubMed ID: 10741746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment results of tonsillar lymphoma: a 10-year experience.
    Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
    Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
    Arranz R; Gil-Fernández JJ; Muñoz E; Acevedo A; Sobrino MP; Fernández-Rañada JM
    Sangre (Barc); 1998 Jun; 43(3):179-84. PubMed ID: 9741222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New prognostic factors in the treatment of patients with stage-III Hodgkin's disease].
    Girshovich MM; Kanaev SV; Pozharisskiĭ KM; Golovanov SG; Barbashov AI
    Vopr Onkol; 2010; 56(4):424-9. PubMed ID: 20968021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
    Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M
    Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognosis of localized diffuse large B-cell lymphoma in younger patients.
    Møller MB; Christensen BE; Pedersen NT
    Cancer; 2003 Aug; 98(3):516-21. PubMed ID: 12879468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials.
    Sibon D; Fournier M; Brière J; Lamant L; Haioun C; Coiffier B; Bologna S; Morel P; Gabarre J; Hermine O; Sonet A; Gisselbrecht C; Delsol G; Gaulard P; Tilly H
    J Clin Oncol; 2012 Nov; 30(32):3939-46. PubMed ID: 23045585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimate of expected survival at diagnosis in Hodgkin's disease: a means of weighting prognostic factors and a tool for treatment choice and clinical research. A report from the International Database on Hodgkin's Disease (IDHD).
    Gobbi PG; Comelli M; Grignani GE; Pieresca C; Bertoloni D; Ascari E
    Haematologica; 1994; 79(3):241-55. PubMed ID: 7926973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current clinical trials for the treatment of adult advanced-stage Hodgkin's disease: GELA experiences. Groupe d'Etudes des Lymphomes de l'Adulte.
    Ferme C; Mounier N; Diviné M;
    Ann Oncol; 2002; 13 Suppl 1():96-7. PubMed ID: 12078912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Responses of advanced esophageal cancer to chemotherapy and prognostic factors: a report of 138 cases].
    Liu AN; Huang J; Cai RG; Shi DM; He XH; Zhang XR; Shi YK; Wang JW
    Ai Zheng; 2008 Apr; 27(4):400-6. PubMed ID: 18423127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognostic factors concerning the survival time of Hodgkin's disease stage III and IV, treated with cytostatic agents].
    Stoller U; Brunner K
    Schweiz Med Wochenschr; 1976 Apr; 106(15):507-13. PubMed ID: 982004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A weekly regimen with dose escalation of doxorubicin for patients with advanced Hodgkin's lymphoma: results of a phase II study of the Groupe d'Etudes des Lymphomes de l'Adulte (GELA).
    Fermé C; Brice P; Michallet AS; Lederlin P; Diviné M; Casasnovas O; Devidas A; Anglaret B; Cazals-Hatem D; Mounier N;
    Leuk Lymphoma; 2007 Apr; 48(4):691-8. PubMed ID: 17454626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The significance of mediastinal involvement and other risk factors for survival in patients with Hodgkin's disease].
    Melínova L; Hermanská Z; Halíková J; Dienstbier Z; Vacková B; Zámecník J; Skala E
    Vnitr Lek; 1995 May; 41(5):307-12. PubMed ID: 7653060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multivariate analysis of Hodgkin's disease prognosis. Fitness and use of a directly predictive equation.
    Gobbi PG; Gobbi PG; Mazza P; Zinzani PL
    Haematologica; 1989; 74(1):29-38. PubMed ID: 2498180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors in Hodgkin's disease.
    Dienstbier Z; Foltýnová V; Hermanská Z; Citavý M; Beska F; Cerný J; Hynek J; Koutná J; Machácek J; Zemanová E
    Neoplasma; 1986; 33(6):731-5. PubMed ID: 3808128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.